| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8629654 | Diabetes Research and Clinical Practice | 2018 | 27 Pages |
Abstract
Besides improvement in glucose control and reduction of SBP obtained by both treatments, lower blood pressure variability was observed in patients receiving vildagliptin. Glucose variability remained unaffected by both interventions and the exercise session.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Aline Fofonka, PatrÃcia Martins Bock, Karina Rabello Casali, Anderson Donelli da Silveira, Felipe Marques da Rosa, Gabriela Berlanda, Beatriz D. Schaan,